Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Prescient Therapeutics Limited ( (AU:PTX) ).
Prescient Therapeutics Limited announced an extension of the closing date for its proposed securities issue to July 22, 2025. This update provides additional time for stakeholders to participate in the securities purchase plan, potentially impacting the company’s capital-raising efforts and market positioning.
More about Prescient Therapeutics Limited
Prescient Therapeutics Limited operates in the biotechnology industry, focusing on developing innovative cancer therapies. The company is dedicated to advancing its pipeline of targeted and personalized medicine to improve patient outcomes in oncology.
Average Trading Volume: 971,908
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$33.82M
For detailed information about PTX stock, go to TipRanks’ Stock Analysis page.